Spanish drug editor wins case brought by Merck, Sharp & Dohme

High Court Invalidates Shionogi EPC Patent to HIV Drug “Tivicay” Today in Merck Sharp and Dohme

Networks of innovation: vaccine development at Merck, Sharp & Dohme, and Mulford, 1895–1995

as PTSD was not discovered, but rather was created, or "glued together", "by the practices, technologies and narratives with which it is diagnosed, studied, treated and represented. . ." (p. 5), a claim he convincingly supports in this thought-provoking, though uneven book. Significantly, Young does not deny the "reality" of post-traumatic suffering; rather his goal is to lay bare the construct...

Public Assessment Report Paediatric data COSOPT eye drops solution Dorzolamide Hydrochloride Timolol Maleate Marketing Autorisation Holder: Merck Sharp & Dohme

Slow but steady wins the drug race

Without the SNF-6 acetylcholine transporter (bottom) mutant muscles fall apart. K im /M ac m ill an they are mutant for various members of the dystrophinglycoprotein complex (DGC), which links intracellular actin to extracellular laminin. But now, Hongkyun Kim, Steven McIntire (University of California, San Francisco, CA), and colleagues suggest that loss of the DGC results in loss of an associ...

Modeling and Simulation at the Interface of Nonclinical and Early Clinical Drug Development

1Global DMPK, Innovative Medicines, AstraZeneca R&D, Södertälje, Sweden; 2Current affiliation: Merck Research Laboratories, Merck & Co., Inc., Upper Gwynedd, PA, USA; 3European Medicines Agency, London, UK; 4Division of Pharmacology, Leiden Academic Center for Drug Research, Leiden University, Leiden, The Netherlands; 5M&S, Merck Sharp & Dohme, Oss, The Netherlands. Correspondence: SAG Visser (...